+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bladder Drug"

From
Pediatric Bladder Treatment Global Market Report 2024 - Product Thumbnail Image

Pediatric Bladder Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Overactive Bladder Treatment Global Market Report 2024 - Product Thumbnail Image

Overactive Bladder Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Overactive bladder - Pipeline Insight, 2024 - Product Thumbnail Image

Overactive bladder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

The Bladder Drug market is a subset of the Urological Disorders Drugs market, which focuses on treatments for conditions related to the urinary tract. These drugs are used to treat a variety of conditions, including urinary incontinence, overactive bladder, bladder cancer, and urinary tract infections. Bladder drugs are typically administered orally, topically, or through injections. Commonly prescribed bladder drugs include anticholinergics, antispasmodics, and alpha-blockers. The Bladder Drug market is highly competitive, with a range of generic and branded products available. Companies in the market include Astellas Pharma, Allergan, Pfizer, Merck, and Sanofi. Show Less Read more